COVID-19 causes twice as much liver damage at the cellular level. First, hepatocellular damage occurs, resulting in mild steatosis, lobular and portal inflammation, and areas of apoptosis and necrosis. This type of damage raises aspartate aminotransferase (AST) and alanine transaminase (ALT) levels.Feb 7, 2023
https://www.ncbi.nlm.nih.gov › pmc
Liver involvement in patients with COVID-19 infection - NCBI
COVID-19 causes twice as much liver damage at the cellular level. First, hepatocellular damage occurs, resulting in mild steatosis, lobular and portal inflammation, and areas of apoptosis and necrosis. This type of damage raises aspartate aminotransferase (AST) and alanine transaminase (ALT) levels.Feb 7, 2023 https://www.ncbi.nlm.nih.gov › pmc Liver involvement in patients with COVID-19 infection - NCBI
0 Comments 0 Shares 335 Views 0 Reviews